Patents by Inventor Jeffrey R. Dahlen
Jeffrey R. Dahlen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11922220Abstract: Embodiments of systems, apparatuses and methods provide enhanced function as a service (FaaS) to users, e.g., computer developers and cloud service providers (CSPs). A computing system configured to provide such enhanced FaaS service include one or more controls architectural subsystems, software and orchestration subsystems, network and storage subsystems, and security subsystems. The computing system executes functions in response to events triggered by the users in an execution environment provided by the architectural subsystems, which represent an abstraction of execution management and shield the users from the burden of managing the execution. The software and orchestration subsystems allocate computing resources for the function execution by intelligently spinning up and down containers for function code with decreased instantiation latency and increased execution scalability while maintaining secured execution.Type: GrantFiled: April 16, 2019Date of Patent: March 5, 2024Assignee: Intel CorporationInventors: Mohammad R. Haghighat, Kshitij Doshi, Andrew J. Herdrich, Anup Mohan, Ravishankar R. Iyer, Mingqiu Sun, Krishna Bhuyan, Teck Joo Goh, Mohan J. Kumar, Michael Prinke, Michael Lemay, Leeor Peled, Jr-Shian Tsai, David M. Durham, Jeffrey D. Chamberlain, Vadim A. Sukhomlinov, Eric J. Dahlen, Sara Baghsorkhi, Harshad Sane, Areg Melik-Adamyan, Ravi Sahita, Dmitry Yurievich Babokin, Ian M. Steiner, Alexander Bachmutsky, Anil Rao, Mingwei Zhang, Nilesh K. Jain, Amin Firoozshahian, Baiju V. Patel, Wenyong Huang, Yeluri Raghuram
-
Publication number: 20110065210Abstract: The present invention relates to materials and procedures for evaluating the prognosis of patients suffering from acute coronary syndromes. In particular, the level of BNP, or a marker related to BNP, in a patient sample, alone or in combination with one or more other prognostic markers, provides prognostic information useful for predicting near-term morbidity and/or mortality across the entire spectrum of acute coronary syndromes, including unstable angina, non-ST-elevation non-Q wave myocardial infarction, ST-elevation non-Q wave MI, and transmural (Q-wave) MI.Type: ApplicationFiled: September 2, 2010Publication date: March 17, 2011Inventors: Jeffrey R. Dahlen, Kenneth F. Buechler, Gunars E. Valkirs
-
Patent number: 7632647Abstract: The present invention relates to materials and procedures for evaluating the prognosis of patients suffering from acute coronary syndromes. In particular, the level of BNP, or a marker related to BNP, in a patient sample, alone or in combination with one or more other prognostic markers, provides prognostic information useful for predicting near-term morbidity and/or mortality across the entire spectrum of acute coronary syndromes, including unstable angina, non-ST-elevation non-Q wave myocardial infarction, ST-elevation non-Q wave MI, and transmural (Q-wave) MI.Type: GrantFiled: April 13, 2001Date of Patent: December 15, 2009Assignee: Biosite IncorporatedInventors: Jeffrey R. Dahlen, Kenneth F. Buechler, Gunars E. Valkirs
-
Patent number: 7608406Abstract: The present invention relates to methods for the diagnosis and evaluation of stroke and transient ischemic attacks. A variety of markers are disclosed for assembling a panel for such diagnosis and evaluation. In various aspects, the invention provides methods for early detection and differentiation of stroke types and transient ischemic attacks, for determining the prognosis of a patient presenting with stroke symptoms, and identifying a patient at risk for cerebral vasospasm. Invention methods provide rapid, sensitive and specific assays to greatly increase the number of patients that can receive beneficial stroke treatment and therapy, and reduce the costs associated with incorrect stroke diagnosis.Type: GrantFiled: June 23, 2004Date of Patent: October 27, 2009Assignee: Biosite, Inc.Inventors: Gunars E. Valkirs, Jeffrey R. Dahlen, Howard J. Kirchick, Kenneth F. Buechler
-
Patent number: 7427490Abstract: The present invention relates to methods for the diagnosis and evaluation of stroke and transient ischemic attacks. In a particular aspect, patient samples are analyzed for the presence or amount of a panel of markers comprising one or more specific markers for cerebral injury and one or more non-specific markers for cerebral injury. In an alternative aspect, samples are analyzed for B-type natriuretic peptide. A variety of markers are disclosed for assembling a panel for such diagnosis and evaluation. In various aspects, the invention provides methods for early detection and differentiation of stroke types and transient ischemic attacks, for determining the prognosis of a patient presenting with stroke symptoms, and identifying a patient at risk for cerebral vasospasm. Invention methods provide rapid, sensitive and specific assays to greatly increase the number of patients that can receive beneficial stroke treatment and therapy, and reduce the costs associated with incorrect stroke diagnosis.Type: GrantFiled: August 20, 2002Date of Patent: September 23, 2008Assignee: Biosite IncorporatedInventors: Gunars E. Valkirs, Jeffrey R. Dahlen, Howard J. Kirchick, Kenneth F. Buechler
-
Publication number: 20040253637Abstract: The present invention provides methods for the identification and use of diagnostic markers for differential diagnosis of diseases. In various aspects, the invention relates to methods and compositions able to determine the presence or absence of one, and preferably a plurality, of diseases that exhibit one or more similar or identical symptoms. Such methods and compositions can be used to provide assays and assay devices for use in determining the disease underlying one or more non-specific symptoms exhibited in a clinical setting.Type: ApplicationFiled: June 24, 2003Publication date: December 16, 2004Applicant: Biosite IncorporatedInventors: Kenneth F. Buechler, Alan Maisel, Joseph Michael Anderberg, Paul H. McPherson, Jeffrey R. Dahlen, Howard J. Kirchick
-
Publication number: 20040219509Abstract: The present invention relates to methods for the diagnosis and evaluation of stroke and transient ischemic attacks. A variety of markers are disclosed for assembling a panel for such diagnosis and evaluation. In various aspects, the invention provides methods for early detection and differentiation of stroke types and transient ischemic attacks, for determining the prognosis of a patient presenting with stroke symptoms, and identifying a patient at risk for cerebral vasospasm. Invention methods provide rapid, sensitive and specific assays to greatly increase the number of patients that can receive beneficial stroke treatment and therapy, and reduce the costs associated with incorrect stroke diagnosis.Type: ApplicationFiled: November 14, 2003Publication date: November 4, 2004Applicant: Biosite, Inc.Inventors: Gunars E. Valkirs, Jeffrey R. Dahlen, Howard J. Kirchick, Kenneth F. Buechler
-
Publication number: 20040171064Abstract: The present invention relates to materials and procedures for evaluating the prognosis of patients suffering from acute coronary syndromes. In particular, the level of BNP, or a marker related to BNP, in a patient sample, alone or in combination with one or more other prognostic markers, provides prognostic information useful for predicting near-term morbidity and/or mortality across the entire spectrum of acute coronary syndromes, including unstable angina, non-ST-elevation non-Q wave myocardial infarction, ST-elevation non-Q wave MI, and transmural (Q-wave) MI.Type: ApplicationFiled: March 13, 2003Publication date: September 2, 2004Applicant: Biosite IncorporatedInventors: Jeffrey R. Dahlen, Kenneth F. Buechler, Gunars E. Valkirs
-
Publication number: 20040126767Abstract: The present invention relates to methods and system for the diagnosis diseases or conditions. In a particular aspect, a disclosed method for determining a panel includes calculating a panel response for each patient in a set of diseased patients and in a set of non-diseased patients. The panel response is a function of the value of each of a plurality of markers in a panel of markers. The method also includes calculating a value for an objective function. The objective function is indicative of the effectiveness of the panel. The steps of calculating a panel response for each patient and calculating a value for an objective function are iterated by varying at least one of the parameters relating to the panel response function and a sense of each marker to facilitate optimization of the objective function. The objective function may be a measure of an overlap of panel responses of diseased patients and panel responses of non-diseased patients.Type: ApplicationFiled: December 27, 2002Publication date: July 1, 2004Applicant: Biosite IncorporatedInventors: Joseph Michael Anderberg, Kenneth F. Buechler, Paul H. McPherson, Howard J. Kirchick, Jeffrey R. Dahlen
-
Publication number: 20040121350Abstract: The present invention relates to methods and system for the diagnosis diseases or conditions. In a particular aspect, a disclosed method for determining a panel includes calculating a panel response for each patient in a set of diseased patients and in a set of non-diseased patients. The panel response is a function of the value of each of a plurality of markers in a panel of markers. The method also includes calculating a value for an objective function. The objective function is indicative of the effectiveness of the panel. The steps of calculating a panel response for each patient and calculating a value for an objective function are iterated by varying at least one of the parameters relating to the panel response function and a sense of each marker to facilitate optimization of the objective function. The objective function may be a measure of an overlap of panel responses of diseased patients and panel responses of non-diseased patients.Type: ApplicationFiled: April 8, 2003Publication date: June 24, 2004Applicant: Biosite IncorporatedInventors: Joseph Michael Anderberg, Kenneth F. Buechler, Paul H. McPherson, Howard J. Kirchick, Jeffrey R. Dahlen
-
Publication number: 20030119064Abstract: The present invention relates to methods for the diagnosis and evaluation of stroke and transient ischemic attacks. In a particular aspect, patient samples are analyzed for the presence or amount of a panel of markers comprising one or more specific markers for cerebral injury and one or more non-specific markers for cerebral injury. In an alternative aspect, samples are analyzed for B-type natriuretic peptide. A variety of markers are disclosed for assembling a panel for such diagnosis and evaluation. In various aspects, the invention provides methods for early detection and differentiation of stroke types and transient ischemic attacks, for determining the prognosis of a patient presenting with stroke symptoms, and identifying a patient at risk for cerebral vasospasm. Invention methods provide rapid, sensitive and specific assays to greatly increase the number of patients that can receive beneficial stroke treatment and therapy, and reduce the costs associated with incorrect stroke diagnosis.Type: ApplicationFiled: August 20, 2002Publication date: June 26, 2003Inventors: Gunars E. Valkirs, Jeffrey R. Dahlen, Howard J. Kirchick, Kenneth F. Buechler
-
Publication number: 20030022235Abstract: The present invention relates to materials and procedures for evaluating the prognosis of patients suffering from acute coronary syndromes. In particular, the level of BNP, or a marker related to BNP, in a patient sample, alone or in combination with one or more other prognostic markers, provides prognostic information useful for predicting near-term morbidity and/or mortality across the entire spectrum of acute coronary syndromes, including unstable angina, non-ST-elevation non-Q wave myocardial infarction, ST-elevation non-Q wave MI, and transmural (Q-wave) MI.Type: ApplicationFiled: April 13, 2001Publication date: January 30, 2003Inventors: Jeffrey R. Dahlen, Kenneth F. Buechler, Gunars E. Valkirs